Clinical Trials Directory

Trials / Completed

CompletedNCT02750631

Out-patient Wake Therapy, Light Therapy and Sleep Phase Advance for Depression

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
New York State Psychiatric Institute · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Depressed patients miss a night of sleep (Wake Night), then sleep at predetermined times ending at their desired sleep time. Beginning the morning following their Wake Night, patients sit in front of a bright light, continuing morning bright light and specified sleep time for six weeks with weekly visits measuring depressive symptoms.

Detailed description

Nonpsychotic, nonbipolar, physically healthy depressed patients keep sleep, mood and energy logs for a week, complete the Morningness-Eveningness Questionnaire (measuring "morningness" and "eveningness") and determine the time patients want to sleep. Patients then miss a night of sleep and subsequently are allowed later and later sleep times until patients are sleeping at their desired time. Beginning the morning following their Wake Night, patients sit in front of bright lights at their intended wake-up time for the next six weeks and once their allowed sleep time is their intended sleep time, patients also continue to only be allowed to sleep between those times (e.g., 11 p.m. to 7 a.m.). Daily sleep, energy and mood logs and activity monitoring are maintained throughout with weekly clinician ratings. In additional, daily telephone check ins occur during the first week following the Wake Night both to be sure the patient is following the protocol and to obtain symptom ratings. Saliva to be measured for melatonin is collected prior to and following sleep adjustment.

Conditions

Interventions

TypeNameDescription
OTHERTriple TherapyThe intervention consists of three interventions: missing a night of sleep, early morning bright lights and sleep phase advance

Timeline

Start date
2014-04-01
Primary completion
2017-07-01
Completion
2017-07-01
First posted
2016-04-25
Last updated
2017-08-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02750631. Inclusion in this directory is not an endorsement.